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Apparent absence 
of Batrachochytrium 
salamandrivorans in wild  
urodeles in the United Kingdom
Andrew A. Cunningham  1, Freya smith1,2, trevelyan J. McKinley3, Matthew W. perkins1, 
Liam D. Fitzpatrick1, owen N. Wright1,4 & Becki Lawson  1
Whether an infectious disease threat to wildlife arises from pathogen introduction or the increased 
incidence of an already-present agent informs mitigation policy and actions. the prior absence of a 
pathogen can be difficult to establish, particularly in free-living wildlife. Subsequent to the epidemic 
emergence of the fungus, Batrachochytrium salamandrivorans (Bsal), in mainland Europe in 2010 and 
prior to its detection in captive amphibians in the United Kingdom (UK), we tested archived skin swabs 
using a Bsal-specific qPCR. These samples had been collected in 2011 from 2409 wild newts from ponds 
across the UK. All swabs were negative for Bsal. Bayesian hierarchical modelling suggests that Bsal 
was absent from, or present at very low levels in, these ponds at the time of sampling. Additionally, 
surveillance of newt mortality incidents, 2013–2017, failed to detect Bsal. As this pathogen has been 
shown to be widespread in British captive amphibian collections, there is an urgent need to raise 
awareness of the importance of effective biosecurity measures, especially amongst people with captive 
amphibians, to help minimise the risk of Bsal spreading to the wild. Continued and heightened wild 
amphibian disease surveillance is a priority to provide an early warning system for potential incursion 
events.
The chytrid fungus, Batrachochytrium salamandrivorans (Bsal) is a recently-discovered, emerging pathogen 
causing epidemic mortality and population declines of urodele amphibians (newts and salamanders) in The 
Netherlands, Belgium and Germany1,2. The detection of Bsal in archived specimens exclusively from Asia and its 
widespread presence in China and Vietnam in the absence of disease, suggests that this pathogen is likely to have 
originated from Asia and was recently introduced into Europe2–4. In addition to the index site of emergence in 
Europe in a population of wild fire salamanders (Salamandra salamandra) on the Belgium/Netherlands border, 
the pathogen has recently been identified in wild amphibians in Germany5. Whereas no evidence of Bsal infection 
has been found on screening captive pet salamanders in the United States of America6, or on limited testing in 
Canada7, the pathogen has been detected in urodeles sampled from zoological and hobbyist collections in Europe, 
including in the United Kingdom (UK)8–10.
Although this newly-discovered pathogen can infect anurans, it is only known to cause disease in urodeles, 
albeit with huge variance in infection outcome amongst species, ranging from tolerance to death2,11. There are 
three native species of urodele in the UK: the great crested newt (Triturus cristatus), the smooth newt (Lissotriton 
vulgaris) and the palmate newt (Lissotriton helveticus). Whilst all three newt species are present across Great 
Britain (i.e. England, Scotland and Wales), only the smooth newt is present in Northern Ireland. The great crested 
newt is a Biodiversity Action Plan priority species, is listed on Appendix II of the Bern Convention and on 
Annexes II and IV of the EU Natural Habitats Directive, and is known to be susceptible to lethal infection with 
Bsal2,11. Infection with Bsal has been documented in smooth newts at multiple sites in mainland Europe5. In con-
trast, experimental challenge of the palmate newt with Bsal demonstrated resistance to infection in this species2. 
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The alpine newt (Ichthyosaura alpestris), which is susceptible to fatal chytridiomycosis following experimental 
challenge with Bsal, and which has been found to be infected in the wild in mainland Europe2,5, is an invasive 
species in the UK with naturalised populations widely distributed across England and in parts of Scotland and 
Wales12. As all wild urodeles in the UK are newts, we use the latter term from here on to refer to these species.
In this study, we capitalise on existing sample archives and on disease surveillance to evaluate the likelihood of 
Bsal presence in wild newts in the UK, with the aim of informing mitigation strategies and contingency planning 
to prevent the incursion and impact of this pathogen on UK wildlife.
Methods
skin swab sample collection. A survey was conducted in 2011 to investigate the spatial distribution of B. 
dendrobatidis (Bd) infection in wild amphibians in the United Kingdom13. Ponds were opportunistically selected 
to obtain a wide geographical coverage across the UK. As far as possible, sampling effort was stratified by region, 
with the number of sampled ponds commensurate with county size; easily accessible ponds were often preferen-
tially selected. Non-invasive skin swabs were collected in the field by trained herpetologists and field ecologists 
and were tested in the laboratory for Bd using qPCR13. This study was approved by the Zoological Society of 
London’s Ethics Committee (WLE534) and all methods were performed in accordance with the relevant guide-
lines and regulations. Extracted DNA samples were archived at −80 °C and were consequently available for the 
current study. All available DNA extracts from both native and introduced newt species were tested using Bsal-
specific qPCR as described by Blooi et al.14.
Bayesian hierarchical model. The results of the Bsal qPCR analyses were pooled across all four newt spe-
cies and were used to develop a Bayesian hierarchical model to estimate the infection prevalence in newts and 
ponds in the UK, as follows:
Let Yi be the number of positive swabs in pond i ( = …i P1, , ), where =P 103 is the number of ponds. 
Similarly, let Xi be the number of newts sampled in pond i. To capture whether ponds are infected or not, we 
introduce a latent variable Zi, such that
=



 .
Z i0 if pond is uninfected,
1 otherwisei
The number of positive swabs is then modelled as:
~Y X pBin( , ),i i i
where
=p Z p p ,i i i
D sens
pi
D is the prevalence of the pathogen in pond i, given that pond i is infected, and psens is the sensitivity of the diag-
nostic test (we assume 100% specificity here15). To complete the Bayesian specification, we use the following prior 
distributions
~
~
~
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where p is the proportion of ponds that are infected. This approach allows us to estimate the marginal posterior 
distribution for the key parameter p, which integrates across the other sources of uncertainty (Fig. 1). We used 
vague prior distributions for pi
D and p to be conservative in our estimates. The posterior mean for each Zi pro-
vides an estimate of the posterior probability that pond i was infected (see Fig. 2). Due to identifiability con-
straints, it was necessary to fix the sensitivity parameter psens, and as such we decided to fit the model to a range 
of values, corresponding to psens = 0.5, 0.6, 0.7, 0.8, 0.9 and 1. Lower values of psens will result in higher false 
negative rates, which in turn allows for larger estimates of pi
D and p. From the literature we expect psens to be 
much larger than 0.5 (>0.9 even being conservative15). Of course, there may be some differences between this 
laboratory experiment and field sampling, and hence we explore a range of options, but for which we think that 
the lower bound of these choices will correspond to a highly conservative estimate for p.
Bayesian hierarchical modelling is a flexible framework, and our model is similar, in essence, to more com-
plex occupancy models16, in the sense that it uses hierarchical structures to share information between different 
sampling sites. The complexity of our model is limited by the available data; the model could be extended, e.g. to 
analyse differences in infection prevalence between species, if more detailed data become available from future 
studies.
The data analysis and visualisations were conducted in R17, and the model was fitted using the freely available 
WinBUGS package18. All code necessary to repeat the analysis and to produce the figures and tables can be found 
in the Supplementary Methods. The raw data file can be found in the Supplementary Worksheet.
Disease surveillance. Disease surveillance of wild amphibians was conducted across Great Britain, 2013–
2017 inclusive. Reports of sick or dead amphibians, regardless of the perceived cause of illness or death, were 
solicited from members of the public. Carcasses were retrieved for post-mortem examination when the state of 
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Figure 1. Posterior distributions for the mean prevalence of infected ponds. Facets denote different 
assumptions for the sensitivity of the diagnostic test.
Figure 2. Posterior probability of infection for individual ponds. Facets denote different assumptions for the 
sensitivity of the diagnostic test.
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preservation permitted and these were examined using a systematic inspection protocol of the internal and exter-
nal systems19. A post-mortem skin swab from each animal was examined using Bsal-qPCR.
Results
Retrospective analysis of skin swabs. Archived samples of extracted DNA from skin swabs collected 
in 2011 from 2409 newts at 103 sites (Table 1; Supplementary Worksheet) were available for the retrospective 
detection of Bsal. All three native newt species (L. vulgaris, L. helveticus & T. cristatus) and one invasive species (I. 
alpestris) were sampled; all tested qPCR negative for Bsal.
Using our Bayesian hierarchical model we explored the likely range of values for the posterior probability that 
any randomly selected pond was infected (or alternatively, an estimate of the posterior proportion of infected 
ponds). This is given by the parameter p in the model specification. The Bayesian framework produces a distribu-
tion of possible outcomes for different test sensitivities (Fig. 1). From these distributions we derived point esti-
mates and uncertainty bounds by calculating the posterior means and the area of highest posterior density (HPD) 
intervals (Table 2). These HPD intervals correspond to intervals between which we are 95% confident that the 
true value of the parameter lies. We also explored the posterior probabilities of infection for each individual pond, 
which are derived from the posterior means for the zi terms and are shown in Fig. 2.
Since we did not find any Bsal-positive swabs, the differences in the estimated posterior probabilities of infec-
tion for individual ponds correspond to differences in the number of samples analysed, with larger estimated 
values corresponding to ponds with low numbers of samples, which in turn corresponds to a higher probability of 
missing infection if it was indeed present in that pond. For ponds where smaller numbers of samples were taken, 
there is more uncertainty as to whether a pond was infected or not, which translates to higher estimates of the 
posterior probabilities of infection.
These results suggest that even with highly conservative estimates of the test sensitivity, the available data 
provide strong evidence that the proportion of Bsal-infected ponds is, at worst, very small (a 95% posterior prob-
ability that the proportion of infected ponds in the population is smaller than 3.3%). The use of vague prior 
distributions also means that the uncertainties in the posterior distributions will be larger than if we used more 
informative prior distributions, adding more weight to our conclusions that Bsal is unlikely to have been present 
in any of the ponds sampled, or if present at all, only present at very low levels. The posterior mean estimate for 
the proportion of infected ponds in the population is 1.1% in the worst-case scenario, and within the individual 
ponds sampled the largest posterior probability of infection was around 0.7%.
Disease surveillance. We received 60 reports of wild newt mortality (+/− morbidity) from 40 sites in Great 
Britain, March 2013–December 2017 (mean of 1.6 dead newts per site, range 1–10). Of these, 43 animals (32 L. 
vulgaris, 7 T. cristatus, 1 I. alpestris and 3 unidentified species) from 18 sites were examined post mortem and their 
skin swabs were analysed. None were qPCR-positive for Bsal.
Discussion
It is unusual to be able to examine such a large and relevant dataset prior to the detection of an emerging infec-
tious disease in free-living wildlife. Our results demonstrate the value of disease and pathogen surveillance20 
and of archiving samples21. While we found no evidence of Bsal infection in any of the 2409 samples collected 
from ponds sampled in 2011, it is not possible to conclude that the UK is free of Bsal in the wild because the 
available sample archive collected from 103 sites is just a subset of the newt population in the UK. Furthermore, 
Species
Sex Age
Total No. of sites No. of positive samplesMale Female Unknown Adult Juvenile
Lissotriton vulgaris 417 349 18 765 19 784 69 0
Lissotriton helveticus 655 484 22 1138 23 1161 63 0
Triturus cristatus 149 136 16 279 22 301 40 0
Ichthyosaura alpestris 81 74 8 144 19 163 12 0
All species 1302 1043 64 2326 83 2409 103 0
Table 1. Species tested for Batrachochytrium salamandrivorans using archived DNA extracted from skin swabs 
collected across the United Kingdom in 2011.
Sensitivity Mean Lower HPD Upper HPD
0.5 0.011 3.4e-06 0.033
0.6 0.01 3.2e-07 0.031
0.7 0.011 2.5e-08 0.031
0.8 0.01 1.1e-06 0.031
0.9 0.01 3.2e-07 0.030
1 0.01 5.1e-06 0.030
Table 2. Posterior means and 95% highest posterior density (HPD) intervals for the proportion of infected 
ponds at different sensitivities of detection of Batrachochytrium salamandrivorans.
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pond selection was not random, and thus we must be careful when extrapolating our results to all ponds in the 
UK. Nonetheless, we did try to select ponds to give a wide spatial coverage. Indeed, one criterion for pond selec-
tion was accessibility13 and relatively frequent visitation compared to more remote ponds might be expected to 
increase the risk of exposure to Bsal, e.g. via contaminated fomites or the release of infected animals, and hence 
the likelihood of a study site testing positive for this pathogen. In combination with disease surveillance data 
from 2013–2017 (which also found no evidence of Bsal), our results indicate that Bsal is either not present in wild 
amphibians in the UK, or that its presence is localised and/or at low prevalence, consistent with a recent intro-
duction. Given these results, for the purposes of disease mitigation and management strategy development, it is 
appropriate to adopt the precautionary principle and develop plans based on the assumption that wild amphibi-
ans in the UK are currently Bsal-free.
Modelling studies for Bsal in wild urodele populations in mainland Europe, where fire salamanders occur, 
suggest that disease outbreaks may occur at very low host population densities and can lead to the local extirpa-
tion of susceptible species within a few months22. Equivalent models do not yet exist for the UK. However, given 
that at least one UK native species (T. cristatus) is known to be susceptible to lethal infection with Bsal2, a strategy 
to prevent human-mediated introduction is a priority23. Crucially, this includes implementation of biosecurity 
measures24 within captive collections (to prevent introduction of Bsal from existing sources in the UK) and ade-
quate quarantine and testing of imported amphibians (to avoid importing infection from new sources such as 
private collections or the amphibian trade). In addition, continued surveillance of wild populations is essential 
for early detection of incursion to enable mitigation protocols to be implemented in a timely manner to ensure 
maximum likelihood of success. Experience from mainland Europe, and efforts to develop treatment options for 
individuals and sites, should be used to help inform potential future control measures10,25,26.
In summary, whilst Bsal infection is known to be present in captive amphibians in the UK, we currently have 
no evidence of infection in free-living populations in this country. Since captive amphibians, including urodeles, 
continue to be imported into the UK10, the risk of incursion of this pathogen into UK wildlife is likely to continue. 
The European Commission recently implemented controls to prevent the spread of Bsal within the European 
Union (EU)27, but the small-scale trade of urodeles amongst hobbyists is unregulated and the introduction of 
costs and other hurdles associated with complying with the new EU regulations might direct more amphibian 
trade along unregulated pathways. Thus, raising the profile of Bsal within the hobbyist community and providing 
guidance on developing and maintaining Bsal-free collections is of key importance to minimising the risk of Bsal 
infection to both captive and free-living amphibians.
Data Availability
All materials, data and associated protocols have been made available in the manuscript, Supplementary Methods 
and Supplementary Worksheet.
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